A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
Original Article
E. Vichinsky, C.C. Hoppe, K.I. Ataga, R.E. Ware, V. Nduba, A. El-Beshlawy, H. Hassab, M.M. Achebe, S. Alkindi, R.C. Brown, D.L. Diuguid, P. Telfer, D.A. Tsitsikas, A. Elghandour, V.R. Gordeuk, J. Kanter, M.R. Abboud, J. Lehrer-Graiwer, M. Tonda, A. Intondi, B. Tong, and J. Howard
N Engl J Med 2019;381:509-519
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, August 8, 2021 - 11:59pm.